Comparing Human Albumin Versus Hydroxyethylstarch in Renal Transplant Recipients

Cairo University120 enrolled

Overview

In this study we try to review the possible effects when using modern hydroxyethylstarch solutions 6 % versus albumin 5% during living donor renal transplantation.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

SINGLE

Enrollment

120

Conditions

Anesthesia Morbidity

Interventions

Albumin resuscitationOTHER

Albumin 5% is used as the intra-operative colloid

Hydroxyethylstarch resuscitationOTHER

Hydroxyethyl starch 6% is used as the intra-operative colloid

Albumin 5%DRUG

Infusion of Albumin 5% intra-operatively

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * end stage renal disease, for living donor renal transplantation Exclusion Criteria: * severe cardiac or hepatic dysfunction, re-transplantation, coagulopathy

Locations (1)

Cairo University

Cairo, Egypt

Outcomes

Primary Outcomes

Occurrence of complications

Increased creatinine and/or need for dialysis

Time frame: 7 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.